It differs from BioInformant’
“We created this report by analyzing best practices among the most profitable cord blood banks worldwide,” said BioInformant. “We found several similarities and we also found unique ideas, all of which are documented in this report.”
“The report explores the effect of the newly opened cord blood banks on existing cord blood banks, the reasons specific cord blood banks are dominating the industry, and marketing strategies used by fast-growth companies. It also presents successful distribution and business models as they relate to growth and profits, and it offers insights into the practices of fast growth companies that continue to increase their dominance over companies that are not increasing their revenue stream as quickly.”
The 2013 report examines cord blood industry trends, including data on research activity, grants, patents, and more. It explores the total market size worldwide, as well as market size by geographic region, and presents five-year growth projections. For companies or investors interested in entering the cord blood banking market, this is a critical document.
Additionally, for those who order the report early, Bioinformant is offering a free bonus, BioInformant’
Bioinformant is offering a 5% discount for anyone who orders a pre-release copy of the report prior to March 15, 2013. Please see the Web site, http://www.bioinformant.com/
About Bioinformant Worldwide, LLC
Bioinformant specializes in watching trends within stem cell markets. The company helps clients and investors stay informed about stem cell markets, watch the competition, identify market threats, and know about profitable opportunities before the competition.